Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine
Disease Category: Multiple Sclerosis
Location: United States, MI
Multiple Sclerosis Spasticity Study
The Command Clinical Research Trial is evaluating an investigational medication for the treatment of spasticity due to multiple sclerosis (MS). Spasticity is one of the more common symptoms of MS. Symptoms of spasticity include muscle tightness or stiffness and painful, uncontrollable spasms.
The trial is evaluating the safety and effectiveness of an investigational oral medication that is similar to a currently approved medication, baclofen. The study medication is being evaluated to determine whether it is effective at treating spasticity with twice-daily dosing.
Baclofen is a relatively effective therapy for MS spasticity. However, it has significant limitations, due to how it's absorbed and the length of time that the drug is maintained in the bloodstream. This requires baclofen to be taken 3 to 4 times per day to be effective.
Participating in the Trial
As a participant in the Command trial, you will receive (at no cost):
- Study-related exams and evaluations with an MS Specialist
- Laboratory testing
- Study medication
Plus, you will be reasonably compensated for time and travel.
Patient Inclusion Criteria:
Muscle spasticity due to Multiple Sclerosis.
Patient Exclusion Criteria:
QUEST Research Institute
31000 Telegraph Ste 230
Bingham Farms, MI 48025
Research Center Information: QUEST Research Institute
If you would like to learn more about participating in this study, please send an email message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these